[October 27, 2017]

The Corporate Reputation of Pharma Companies, 2016: Perspective of 98 Latin-American Patient Groups (2017 Edition) - Research and Markets

The "The Corporate Reputation of Pharma Companies, 2016: from the Perspective of 98 Latin-American Patient Groups (2nd Edition)" report has been added to Research and Markets' offering.

These results are derived from a global review of pharma's corporate reputation (conducted November 2016 to early-February 2017).

This report is based on the opinions of 98 Latin-American patient groups, from Argentina (10), Bolivia (2), Brazil (21), Chile (8), Colombia (8), Costa Rica (6), Cuba (1), the Dominican Republic (1), Ecudaor (2), Guatemala (2), exico (27), Panama (1), Peru (2), Uruguay (1), Venezuela (4).

20 specialised in cancer; 9 in neurological conditions; 7 in haemophilia; and other specialties.

15 pharma companies are included in this 2016 Latin-America analysis:

• AbbVie
• AstraZeneca
• Bayer
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Eli Lilly (Lilly)
• GSK
• Janssen (Pharmaceutical companies of Johnson & Johnson)
• Merck & Co
• Novartis
• Pfizer
• Roche
• Sandoz
• Sanofi
• Teva
  

For more information about this report visit https://www.researchandmarkets.com/research/6qxtw7/the_corporate

View source version on businesswire.com: http://www.businesswire.com/news/home/20171027005264/en/

[ Back To TMCnet.com's Homepage ]